newsfilter
← Latest News
ACCESS Newswire·

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / December 15, 2025 / Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, today announced that it has entered into a